The Australian Lung Health Initiative (ALHI) has been granted $28.9 million in funding from the Australian Federal Government's Medical Research Future Fund (MRFF) Frontier Health and Medical Research initiative, to be provided in tranches over the next five years, to achieve medical breakthroughs with the potential to impact on a global scale.
One hour online workshops for University of Adelaide's Life Sciences and Physical Sciences research staff led by University of Adelaide investment partner, IP Group.
Describe your Advanced Materials, or Advanced/Additive Manufacturing research on a page for a chance at $10k
Innovyz are seeking innovations in the areas of Advanced Materials, or Advanced/Additive Manufacturing. To encourage you to think about the commercial opportunities of your research, Innovyz are awarding prizes of $10k for first, $5k for second and $2.5k for third, based on the technical and commercial merit of your work, as evidenced by your poster. Deadline: Friday 19 February 2021.
Researchers at the University of Adelaide have been awarded $1.35 million in funding to accelerate development of a world-first vaccine for the Zika virus.
VivaZome Therapeutics and the University of Adelaide have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.
French barley breeding company SECOBRA is proud to release its first variety in Australia after many years of collaborative research and development with the University of Adelaide.
Amaero International Limited (ASX:3DA), a world leader in metal additive manufacturing, officially launched their Adelaide facility today in partnership with the University of Adelaide. The facility was opened by the South Australian Minister for Innovation and Skills, the Hon. David Pisoni MP.
The Adelaide China Biotech Investment Fund has today been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technologies from South Australia for the global market.